Evaluation of predictive value of total leukocyte count in acute serious bacterial infections in children 1 month to 5 years

Dharmalingam A.; Vignesh C.; Raghupathy N. S.; Sowmiya M.

doi:10.18203/2349-3291.ijcp20170478

Authors

Dharmalingam A. Department of Pediatrics, Aarupadai Veedu Medical College and Hospital, Pondicherry, India
Vignesh C. Department of Pediatrics, Kauvery Hospital, Trichy, Chennai, Tamilnadu, India
Raghupathy N. S. Department of Pediatrics, Aarupadai Veedu Medical College and Hospital, Pondicherry, India
Sowmiya M. Central Research Laboratory, Aarupadai Veedu Medical College and Hospital, Pondicherry, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20170478

Keywords:

Antibiotic therapy, Febrile illness, Serious bacterial infection, Total leukocyte count

Abstract

Background: Fever in a young child is a frequently encountered clinical problem with various causes. Most of them run a benign self-limiting course that requires only symptomatic treatment. However, in a few children the underlying etiology can be a life threatening serious bacterial infection (SBI). Early identification of SBI is warranted because of the need to start antibiotic therapy, often empirical, as soon as possible to prevent morbid sequela. Total leukocyte count (TLC) is with neutrophil predominance is considered to be a surrogate marker of a bacterial infection and facilitating decision - making regarding further evaluation and empiric antibiotic therapy. The purpose of this study was to determine the utility of leukocyte in predicting SBI in a young febrile child and to correlate the leukocyte count with non-serious infection.

Methods: One fifty children, age of 1 month to 60 months with fever > 38°c are included and were analyzed for demographic details, presenting symptoms, physical examination findings, clinical diagnosis, total leukocyte count, peripheral smear study, blood culture, stool culture, CSF analysis, x-ray chest, abdominal ultrasound, CT-brain.

Results: Out of 150 children included in the study, the mean age was 26.7±14.54 months and the average duration of fever was 4.3±1.02 days. The mean leukocyte count was 15016.43±5801.98 cells/cu.mm. 74 children had proven serious bacterial infection (49.3%) and were categorized in Group I and remaining non-serious infection were 50.66% are belonged to Group 2. Urinary tract infection and pneumonia were the most common SBI encountered (31/20/68.91%). The highest TLC counts were seen in children with UTI. Analysis of variance (ANNOVA) did not reveal significant differences in TLC between children with different diagnosis. In Group 2, majority of the etiology was lower respiratory tract infection/inflammation and short febrile illness.

Conclusions: SBI comprise only half of the febrile children with leukocytosis. The predictive accuracy of leukocytosis in diagnosing SBI is poor. Vomiting and seizures probably incite stress mediated leukocytosis and are commonly encountered in febrile child with a high TLC without SBI. Further models with addition of clinical data and other surrogates of infection need to be developed to improve prediction of SBI in a febrile child.

Metrics

Metrics Loading ...

References

Hay AD. The prevalence of symptoms and consultation in pre-school children in the Avon Longitudinal study of parents and children (ALSPAC): a prospective cohort study. Fampract. 2005;22:367-74.

Hefferanan R, Mostashari F, Das D, Karpati A, Kulldorf M, Weiss D. Syndrome surveillance in public health practice, New York City. Emerg Infect Dis. 2004;10:858-64.

Hsiao AL, Chen L, Baker MD. Incidence and predictors of serious bacterial infections among 57-to 180-day-old infants. Pediatrics. 2006;117:1695-701.

Trainor JL, Hampers LC, Krug SE, Listernick R, Children with first-time simple febrile seizures are at low risk of serious bacterial illness. Acad Emerg Med. 2001;8:781-7.

Gowan JE, Bratton L, Klein JO, Finaland M. Basteraemia in febrile children seen in a “walk-in” pediatric clinic. N Engl J Med. 1973;288:1309-12.

Simpkins D, Woods N, Jelfs J, Mcntyre PB, Mengies R, Lawrence G, et al. Modern trends in mortality from meningococcal disease in Australia. Pediatric Infect Dis J. 2009;28:1119-20.

Bleeker SE, Lubse G, Grobbe DE, Donders ART, Moons KGM, Moll HA. Validating and updating a prediction rule for serious bacterial infection in patient with fever with source. Acta Paedia. 2007;1:100-4.

Bruel VA, Hassan HT, Thompson M, Buntinx F, Mant D. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010;375:834-45.

Brook I. Unexplained fever in young children: how to manage severe bacterial infection. BMJ. 2003;327(7423):1094-7.

Baraff LJ, Bass JW, Flesher GR, Klein Jo, McCracken GH, Powell KR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Annals Emergency Med. 1993;22(7):1198-210.

Lee GM, Harper MB. Risk of bacteremia for febrile yong children in the post-haemophilus influenza type-b era. Arch Pediatr Adolesc Med. 1998;152:624-8.

Procop GW, Hartman JS, Sedor F. Laboratory tests in evaluation of acute febrile illness in pediatric emergency room patients. Am J Cin Pathol. 1997;107(1):114-21.

Shah SS, Shofer FS, Seidel JS, Baren JM. Significance of extreme leukocytosis in the evaluation of febrile children. Pediatr Infect Dis J. 2005;24:927-630.

Brauner M, Goldman M, Kozer E. Extreme leukocytosis and the risk of serious bacterial infections in febrile children. Arch Dis Child. 2010;95:209-12.

Craig JC, Williams GJ, Jones M, Codarini M, Macaskill P, Hayen A, et al. The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15,781 febrile illnesses. BMJ. 2010;340:1594.

Rudinsky SL, Carstairs KL, Reardon JM, Simon LV, Riffenburgh Rh, David A, et al. Serious bacterial infections in febrile infants in the post- pneumococcal conjugate vaccine era. Acad Em Erg Med. 2009;16:585-90.

Watt K, Waddle E, Jhaveri R. Changing epidemiology of serious bacterial infections in febrile infants without localizing signs. PLoS One. 2010;5(8):l2448.

Byington CL, Rittichier KK, Bassett KE, Castillo H, Glasgow TS, Daly J, et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin- resistant pathogns. Pediatrics. 2003;111;964.

Elshout G, Monteny M, Woude JC, Koes BW, Berger MY. Duration of fever and serious bacterial infection in children: a systematic review. BMC. 2011;12:33.

Isaacman DJ, Burke BL. Utility of the serum C- Reactive Protein for detection of occult bacterial infection in children. Arch Pediatr Adolesc Med. 2002:156:905-9.

Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics. 2001;108:1275-9.

Lopez FA, Cubells LC, Garcia GJJ, Pou FJ. Spanish society of pediatric emergencies: procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J. 2003;22:895-903.

Pratt A, Attia MW. Duration of fever and markers of serious bacterial infection in young febrile children. Pediatr Int. 2007;49:31-5.

Trautner BW, Caviness AC, Gerlacher GR, Demmler G, Macias CG. Prospective evaluation of the risk of serious bacterial infection in children who present to the emergency department with hyperpyrexia (temperature of 106 degrees F or higher). Pediatrics. 2006;118:34-40.

Mohebbi MR, Holden KR, Mohemmadi M. Peripheral leukocytosis in children with febrile seizures. J Child Neurol. 2004;19(1):47-50.

Stuijvenberg VM, Moll HA, Steyerberg EW, Gijssel EN, Moons KG, Lubsen GJ. The duration of febrile seizures and peripheral leucocytosis. Pediatr. 1998;133(4):557-8.